<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.9-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//ph-ksp.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://ph-ksp.com/ai-imaging-company-qureight-brings-together-leading-pulmonary-hypertension-experts-on-new-scientific-advisory-board-biospace-may-5-2026/</loc>
  <lastmod>2026-05-23T17:00:46Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AI imaging company Qureight brings together leading pulmonary hypertension experts on new Scientific Advisory Board, Biospace, May 5, 2026</news:title>
   <news:publication_date>2026-05-23T17:00:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://ph-ksp.com/new-study-aims-to-see-how-triple-combination-therapy-with-sotatercept-affects-pulmonary-vascular-resistance-in-patient-with-newly-diagnosed-pulmonary-arterial-hypertension/</loc>
  <lastmod>2026-05-23T16:43:48Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>PULMONARY HYPERTENSION</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>New study aims to see how triple combination therapy with sotatercept affects pulmonary vascular resistance in patient with newly diagnosed pulmonary arterial hypertension</news:title>
   <news:publication_date>2026-05-23T16:43:46Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
